All patients were positive for MOG antibodies confirmed by cell-based assays and their diagnoses varied, including ADEM-like presentation (50, 86), tumefactive MS-like lesions (87–89), NMOSD-like phenotype (90, 91), and large white matter lesions with MOG+ antibodies (92). The gene discussed is MOG; the disease is myeloid sarcoma.